KR20160072140A - 상기도 감염 치료용 폴리이노신산-폴리사이티딜산(폴리 (i:c)) 제형 - Google Patents

상기도 감염 치료용 폴리이노신산-폴리사이티딜산(폴리 (i:c)) 제형 Download PDF

Info

Publication number
KR20160072140A
KR20160072140A KR1020167011935A KR20167011935A KR20160072140A KR 20160072140 A KR20160072140 A KR 20160072140A KR 1020167011935 A KR1020167011935 A KR 1020167011935A KR 20167011935 A KR20167011935 A KR 20167011935A KR 20160072140 A KR20160072140 A KR 20160072140A
Authority
KR
South Korea
Prior art keywords
poly
composition
starch
treatment
micrometers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020167011935A
Other languages
English (en)
Korean (ko)
Inventor
디디어 마리오 로데비즈크 클린게레르스
디지크 알렉스 헨리 반
위르겐 멘쉬
Original Assignee
얀센 사이언시즈 아일랜드 유씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 얀센 사이언시즈 아일랜드 유씨 filed Critical 얀센 사이언시즈 아일랜드 유씨
Publication of KR20160072140A publication Critical patent/KR20160072140A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020167011935A 2013-11-06 2014-11-05 상기도 감염 치료용 폴리이노신산-폴리사이티딜산(폴리 (i:c)) 제형 Ceased KR20160072140A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13191742.9 2013-11-06
EP13191742 2013-11-06
PCT/EP2014/073762 WO2015067632A1 (en) 2013-11-06 2014-11-05 Polylnosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections

Publications (1)

Publication Number Publication Date
KR20160072140A true KR20160072140A (ko) 2016-06-22

Family

ID=49517426

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167011935A Ceased KR20160072140A (ko) 2013-11-06 2014-11-05 상기도 감염 치료용 폴리이노신산-폴리사이티딜산(폴리 (i:c)) 제형

Country Status (11)

Country Link
US (1) US20160271165A1 (enExample)
EP (1) EP3065714B1 (enExample)
JP (1) JP6629216B2 (enExample)
KR (1) KR20160072140A (enExample)
CN (1) CN105939709A (enExample)
AU (1) AU2014345667A1 (enExample)
CA (1) CA2929142A1 (enExample)
IL (1) IL245412A0 (enExample)
MX (1) MX2016005883A (enExample)
RU (1) RU2016117398A (enExample)
WO (1) WO2015067632A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102123489B1 (ko) 2020-03-13 2020-06-16 주식회사 휴먼셀바이오 자연살해세포 배양액 조성물 및 이를 이용한 자연살해세포 배양방법

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201406208QA (en) 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
HK1251926A1 (zh) * 2015-05-11 2019-05-03 Janssen Sciences Ireland Uc 用於预防和/或治疗上呼吸道感染的聚肌苷酸-聚胞苷酸(聚(i:c))豌豆淀粉制剂
PT3319587T (pt) 2015-11-17 2019-11-20 Bioncotech Therapeutics S L Nova composição farmacêutica que compreende partículas compreendendo um complexo de um polirribonuleótido de cadeia dupla e uma polialquilenoimina
US20200060972A1 (en) 2016-11-16 2020-02-27 Janssen Sciences Ireland Unlimited Company Formulations of polyinosinic acid and polycytidylic acid for the prevention of upper respiratory tract infections
JP2020520368A (ja) * 2017-05-17 2020-07-09 ビオンコテック セラピューティクス エセ．エレ 二本鎖ポリリボヌクレオチドとポリアルキレンイミンとの複合体を含む粒子を含む新規な医薬組成物
US20230338395A1 (en) 2020-04-19 2023-10-26 Ludwig Englmeier Prophylaxis and treatment of coronavirus infection
CN118680868B (zh) * 2023-03-24 2026-04-17 清华大学 一种核酸药物递送系统及其制备和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707644A (en) * 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
CN101229378A (zh) * 2005-05-05 2008-07-30 国家淀粉及化学投资控股公司 用于送递活性剂的组合物
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
CN101491503A (zh) * 2008-12-17 2009-07-29 天津瑞普生物技术股份有限公司 一种用于宠物的聚肌胞滴丸及其制备方法
CN101757018A (zh) * 2008-12-24 2010-06-30 天津瑞普生物技术股份有限公司 一种用于畜禽的聚肌胞干粉及其制备方法
CN102488703A (zh) * 2011-12-15 2012-06-13 天津济命生生物科技有限公司 一种聚肌胞制剂的制备方法和抗肿瘤的用途
SG11201406208QA (en) * 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102123489B1 (ko) 2020-03-13 2020-06-16 주식회사 휴먼셀바이오 자연살해세포 배양액 조성물 및 이를 이용한 자연살해세포 배양방법

Also Published As

Publication number Publication date
JP2016535094A (ja) 2016-11-10
WO2015067632A1 (en) 2015-05-14
US20160271165A1 (en) 2016-09-22
AU2014345667A1 (en) 2016-05-19
EP3065714B1 (en) 2020-02-12
EP3065714A1 (en) 2016-09-14
CN105939709A (zh) 2016-09-14
CA2929142A1 (en) 2015-05-14
MX2016005883A (es) 2016-08-17
RU2016117398A3 (enExample) 2018-08-22
RU2016117398A (ru) 2017-12-11
JP6629216B2 (ja) 2020-01-15
IL245412A0 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
EP3065714B1 (en) Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
AU2013255885B2 (en) Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
US20180353533A1 (en) Polyinosinic-polycytidylic acid (poly (i:c)) pea starch formulation for the prevention and/or treatment of upper respiratory tract infections
US20200060972A1 (en) Formulations of polyinosinic acid and polycytidylic acid for the prevention of upper respiratory tract infections
CN121712513A (zh) 包含黄原胶或褐藻多糖的用于抗流感病毒的组合物
HK1228749A1 (en) Polyinosinic-polycytidylic acid (poly (i:c) formulations for the treatment of upper respiratory tract infections
HK1203390B (en) Polyinosinic-polycytidylic acid (poly(i:c)) formulations for the treatment of upper respiratory tract infections
NL2033127A (en) Compositions and methods for enhancing and expanding infection induced immunity
WO2018217756A1 (en) Oligonucleotide compositions and methods for treating diseases

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20160504

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20191104

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210315

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20210928

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210315

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I